Time-domain heart rate variability in coronary artery disease patients affected by thyroid dysfunction
Related Experiment Video
Updated: May 3, 2026

Calculating Heart Rate Variability from ECG Data from Youth with Cerebral Palsy During Active Video Game Sessions
Published on: June 5, 2019
Colomba Falcone1, Benedetta Matrone, Sara Bozzini
1Interdepartmental Center of Research in Molecular Medicine (CIRMC), University of Pavia.
Insights
Thyroid dysfunction, even when subclinical or treated, significantly impacts heart rate variability (HRV) in coronary artery disease (CAD) patients. These patients face additional cardiovascular risks due to thyroid hormone disturbances.
Area of Science:
- Cardiology
- Endocrinology
- Medical Technology
Background:
- Subclinical thyroid dysfunction (hypothyroidism and hyperthyroidism) negatively affects the cardiovascular system.
- The impact of treated thyroid dysfunction on cardiovascular control remains under-investigated.
Purpose of the Study:
- To analyze time-domain heart rate variability (HRV) in coronary artery disease (CAD) patients with known thyroid diseases.
- To assess the influence of subclinical and treated thyroid dysfunction on cardiovascular control parameters.
Main Methods:
- 24-hour ECG monitoring in 344 CAD patients (174 with thyroid dysfunction, 170 controls).
- Analysis of time-domain HRV parameters including SDNN, RMSSD, TINN, and mean RR.
Main Results:
- HRV parameters were significantly lower in patients with subclinical hypothyroidism and hyperthyroidism compared to controls.
- L-thyroxine treated patients and hyperthyroid patients under treatment showed altered HRV compared to controls.
- Even treated thyroid dysfunction in CAD patients resulted in significantly lower HRV values than in the control group.
Conclusions:
- Patients with both cardiac disease and thyroid disease, including subclinical or treated states, are at increased cardiovascular risk.
- Thyroid hormone disturbances pose an additional risk in patients with coronary artery disease.
Abstract:
Subclinical hypothyroidism and hyperthyroidism have been recognized as clinical entities with negative effects on the cardiovascular system. Moreover, the effect of treated thyroid dysfunction on parameters associated with the cardiovascular control system has been poorly investigated. In the present study we analyzed time-domain heart rate variability in coronary artery disease (CAD) patients with known thyroid diseases. Twenty-four hour ECG monitoring was performed in 344 patients with coronary artery disease (174 with thyroid dysfunction and 170 without thyroid dysfunction used as a control group), using a 3-channel tape recorder. Time domain parameters of heart rate variability (HRV) were definitely lower both in patients with subclinical hypothyroidism and subclinical hyperthyroidism than in the control group, with statistically significant differences in SDNN, RMSSD, TINN, and mean RR for both subgroups. Furthermore, patients on L-thyroxine treatment and restored euthyroidism had generally higher HRV values than patients with subclinical hypothyroidism, nevertheless SDNN, RMSSD, SDNN index, TINN, and mean RR were significantly lower when compared to those of the control group. Significant differences in HRV were also found between hyperthyroid patients under treatment and control group subjects with respect to RMSSD, TINN, and mean RR values. In conclusion, patients with cardiac disease and known thyroid disease, even when the disease is in the subclinical range or despite treatment, should be regarded as patients at additional risk conveyed by thyroid hormone disturbances.
More Related Videos
Related Concept Videos
Hyperthyroidism II: Pathophysiology
Factors Influencing Heart Rate
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
Hypothyroidism II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Regulation of Heart Rates
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
Coronary Artery Disease II: Pathophysiology

